Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ISRCTN51069819Phase 2Completed
Phase 2, randomised, open-label trial of telmisartan in insulin resistance (IR) and human immunodeficiency virus infection (HIV), sponsored by University of Liverpool. Started Mar 2013; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ISRCTN51069819.